IH, Brain Health, and T2D
Darren P Casey · with American Diabetes Association · NCT07173543
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 60–85 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 80
- US sites recruiting
- 1
- Study start
- September 22, 2025
- Record last updated
- March 13, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The purpose of this study is to use a randomized, placebo-controlled study design to rigorously examine the therapeutic potential of intermittent hypoxia (IH) for improving cerebrovascular health in older adults with and without type 2 diabetes mellitus (T2DM).
Being studied: Intermittent Hypoxia 1 (IH1); Intermittent Hypoxia 2 (IH2); SHAM - normoxia
Conditions: Type 2 Diabetes; Aging
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
For 30 patients with documented Type 2 diabetes
Inclusion Criteria
- Willing and able to provide written, signed informed consent after the nature of the study has been explained, and prior to any research-related procedures.
- Age is > or = 60 and \< or = 85 years of age
- Documented Type 2 diabetes
- Scoring 26 or higher on the MoCA test
Exclusion criteria
- diagnosis of type 2 diabetes \< 1 year prior to enrollment
- HbA1c \<6.5% or >10.0%
- body mass index > 40 kg/m 2
- incident cardiovascular events in the last year (heart attack, stroke)
- symptomatic coronary artery disease and/or heart failure
- uncontrolled hypertension
- obstructive sleep apnea
- pulmonary disease
- dementia
- renal impairment with creatinine clearance (eGFR) of \<60 ml/min
- smoking or history of smoking within past one year
30 nondiabetic control subjects will also be studied.
Inclusion criteria
- Willing and able to provide written, signed informed consent after the nature of the study has been explained, and prior to any research-related procedures.
- Age is > or = 60 and \< or = 85 years of age
- Scoring 26 or higher on the MoCA test
Exclusion criteria
- Diagnosis of diabetes (Type 1 or Type 2)
- body mass index > 40 kg/m2
- incident cardiovascular events in the last year (heart attack, stroke)
- symptomatic coronary artery disease and/or heart failure
- uncontrolled hypertension
- obstructive sleep apnea
- pulmonary disease
- dementia
- renal impairment with creatinine clearance (eGFR) of \<60 ml/min
- smoking or history of smoking within past one year
Recruiting US locations
University of Iowa
Iowa City, IA 52242
Site contact: Darren P Casey, PhD
Study contacts (from the official record)
- Darren Casey, PHD · 13193841009 · darren-casey@uiowa.edu
Similar studies in Iowa
All diabetes studies in Iowa →- RecruitingHealthy volunteersEarly Phase 1
Oxidative Stress in Microvascular Dysfunction Following Gestational Diabetes
Anna Stanhewicz, PhD
- Location
- Iowa City, IA
- Eligibility basics
- Ages 18–50 · Women only
- RecruitingHealthy volunteersEarly Phase 1
Role of ET-1, Physical Activity, and Sedentary Behavior in Microvascular Dysfunction Following GDM
Anna Stanhewicz, PhD
- Location
- Iowa City, IA
- Eligibility basics
- Ages 18–50 · Women only
- RecruitingHealthy volunteersPhase 1
The Impact of Gestational Diabetes Mellitus on Cerebral Blood Flow and Cerebrovascular Function After Pregnancy
Anna Stanhewicz, PhD
- Location
- Iowa City, IA
- Eligibility basics
- Ages 18–50 · Women only
- RecruitingHealthy volunteersEarly Phase 1
Metformin for the Treatment of Microvascular Dysfunction After Gestational Diabetes
Anna Stanhewicz, PhD
- Location
- Iowa City, IA
- Eligibility basics
- Ages 18–45 · Women only